US$ 22.68
does semaglutide change your taste Weight-Loss Drug Making People Disgusted by Coffee, Fries Does intervention with GLP-1 receptor
Description
As of April 9, 2026, retatrutide is still in Phase 3 and not FDA-approved

Cardiovascular Benefits: Research has shown that semaglutide can reduce the risk of cardiovascular events, such as heart attacks and strokes, in patients with type 2 diabetes
After the drinking portion ended, participants stayed in a recovery area while their alcohol levels dropped

Results vary from medication

GLP-1 therapy may support weight loss, visceral fat reduction, insulin sensitivity, and cardiometabolic improvement

I could not verify linked articles from any of them except Forbes